Cytochrome P450 polymorphism - Molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 3, 2008, Pages 319-329

  Tomaszewski, Piotr ^a   Kubiak Tomaszewska, Grazyna ^a   Łukaszkiewicz, Jacek ^a   Pachecka, Jan ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

CYP alleles; Cytochrome P450; Drug biotransformation; Genetic polymorphism of CYP; Pharmacogenetics; Poor metabolizers; Ultra rapid metabolizers

Indexed keywords

CYTOCHROME P450; XENOBIOTIC AGENT;

ALLELE; ARTICLE; CATALYSIS; DNA MICROARRAY; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN GENOME; MOLECULAR BIOLOGY; PHARMACOGENETICS; PSEUDOGENE;

ALLELES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ISOENZYMES; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 45849149992     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ingelman-Sundberg M., Daly A.K., Nebert D.W. (eds.): Human CYP Allele Nomenclature Committe: Allele nomenclature for cytochrome P450 enzymes. www.cypalleles.ki.se.
2. Gerstein M., Zheng D.: Sci. Amer. 295, 48 (2006).
3. Ensembl Human GeneViev: www.ensembl.org.
4. UniProt - The Universal Protein Knowledgebase: www.expasy.org/uniprot.
5. Weizmann Institute of Science: GeneCards: www.geneards.org.
6. Nelson D.: Cytochrome P450 Homepage: drnelson.utmem.edu/CytochromeP450. html
7. rd ed. pp. 1-658, Kluwer Academic/ Plenum Publishers, New York 2005.
8. Entrez Protein. NCBI Sequence Viever v. 2.0. National Center for Biotechnology Information: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmddb.
9. Genatlas Gene Database: www.genatlas.org.
10. Human Gene Lynx: www.genelynx.org.
11. Source. Stanford University, Genetics Department: www.stnford.edu/cgi- bin/source/surcesearch.
12. Clarke B.: Biomed. Sci. 1, 38 (2006).
13. McKinnon R., Evans A.M.: Aust. J. Hosp. Pharm. 30, 102 (2000).
14. Coleman M.: Human Drug Metabolism: An Introduction., pp.-286, Wiley, Hoboken 2005.
15. Raimundo S., Fischer J., Eichelbaum M., Griese E.U., Schwab M., Zanger U.M.: Pharmacogenetics 10, 577 (2000).
16. Hasler J.A., Estabrook R., Murray M., et al.: Mol. Aspects Med. 20, 1 (1999).
17. Meyer U.A., Zanger U.M.: Annu. Rev. Pharmacol. Toxicol. 37, 269 (1997).
18. Wen X: In vitro approaches in evaluation and predication of drug-drug interactions involving the inhibition of cytochrome P450 enzymes. Dissertation, University of Helsinki, 2002, http://ethesis.helsinki.fi.